Development of rapid, point of care, immunodiagnostic test for detection of the SARS-CoV-2 (COVID-19)

Read the original press release here St. Louis, MO (April 27 2020) – Leinco Technologies, Inc., a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, conjugates and provider of custom manufacturing services to the diagnostic and biopharmaceutical industries, today announced an agreement with Vanderbilt University Medical Center (VUMC) to scale up production of its most... Read more

HORIBA Scientific Launches FLUOROLOG-QM Modular Research Grade Spectrofluorometer

4th Generation Fluorolog covers the broadest range of luminescence research Piscataway, NJ April 23rd, 2020   HORIBA Scientific, global leader in measurement and analysis solutions for research and industry, and world leader in Fluorescence solutions, is thrilled to announce the debut of the Fluorolog-QM, the 4th generation Fluorolog. The Fluorolog-QM is the fourth generation of the world famous Fluorolog, all... Read more

Opentrons Partners With Zymo Research to Offer an Affordable, Automated COVID-19 Testing Platform

(BROOKLYN, NY – April 22, 2020) – Zymo Research Corp, a California-based life science reagent company and Opentrons Labworks, Inc, makers of affordable and easy-to-use lab robotics, have partnered to create a robust engine for SARS-CoV-2 molecular testing. As the COVID-19 crisis persists, the need for high-throughput, fast turn-around, and affordable testing platforms will become... Read more

CytoSMART to donate 100 live-cell imaging systems to assist COVID-19 researchers

Caption: BSL-3/-4 labs are welcome to apply for CytoSMART Lux2 live-cell imaging system. To download this image, click here. 22 April 2020, Eindhoven, The Netherlands – CytoSMART Technologies is to donate 100 mini live-cell imaging systems to researchers in high containment labs worldwide. Labs working to combat COVID-19 will benefit from this initiative, as CytoSMART aims to reduce the huge... Read more

Bio-Rad Begins Shipping SARS-COV-2 (COVID-19) Antibody Test That Offers More Than 99 Percent Specificity and 98 Percent Sensitivity

Date: 04/21/2020 HERCULES, Calif. –Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the commercial launch of its SARS-CoV-2 Total Ab test, a blood-based immunoassay kit to help determine if an individual has developed antibodies to SARS-CoV-2, the virus associated with COVID-19 disease. Bio-Rad has... Read more

AMETEK MOCON Supports Sterilization and Medical Gas Industry During COVID-19 Pandemic

Tuesday, April 21, 2020 Minneapolis, MN, (April 21, 2020) – AMETEK MOCON’s Baseline product group, a leading provider of industrial gas chromatographs and gas sensors, is prioritizing support for specific industries to ensure healthcare supplies continue to be delivered during the COVID-19 pandemic. The company will focus on medical personal protective equipment (PPE) suppliers and sterilizers... Read more

Unchained Labs drives Big Lunatic downstream with shockingly accurate protein quantification!

April 21, 2020 – Pleasanton, CA Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, launched its new Fundamentals UV/Vis standards and performance verification protocols for the Big Lunatic platform today. These new tools make it a cinch for researchers to confidently use Big Lunatic anywhere in their... Read more

PrecisionLife offers analytics and resource support to COVID-19 coronavirus research community

Oxford, UK (21 April 2020) – PrecisionLife has confirmed it is extending its relationships with some of the largest COVID-19 collaborative research projects and is now offering free use of its unique analytics platform and support from its data and biomedical science teams to the on-going collaborative efforts of the medical research community in the fight... Read more

Promega successfully completes first fully remote quality surveillance assessment amid COVID-19 restrictions

Biotech manufacturer recommended for continued certification to ISO 9001:2015 and ISO 13485:2016 Madison, WI USA. (April 17, 2020) Promega Corporation announced today it successfully completed its first ever fully remote quality surveillance assessment and is recommended for continued certification to ISO 9001:2015 and ISO 13485:2016. Due to COVID-19 restrictions, the British Standards Institution (BSI) completed its six-day... Read more